EVOME MEDICAL TECHNOLOGIES
Leadership
Mike Seckler
Chief Executive Officer (CEO) of EVOME Medical Technologies
​
Mike Seckler was appointed Permanent Chief Executive Officer (CEO) of EVOME Medical Technologies in July 2023, following one month as interim CEO. He has more than 30 years of life sciences experience commercializing and developing innovative medicines, medical devices, and diagnostics for patients across a wide range of therapeutic areas.
Prior to EVOME, Mike was the COO of FerGene where he was responsible for establishing a groundbreaking joint venture between Blackstone Life Sciences and Ferring International Center SA. He led the global development and commercialization efforts for ADSTILADRIN, an innovative gene therapy approved for the treatment of bladder cancer.
Mike has also held several executive leadership positions with Ferring Pharmaceuticals, a multi-billion-dollar company based in Switzerland, where he was the General Manager of its $100M Canadian subsidiary; Senior Vice President of Global Marketing and Corporate Communications; and Orthopedics Business Unit leader.
Mike honed his expertise at Pfizer and Merck, where he held various leadership positions in marketing, sales, and market access. Mike obtained a B.S. in Health Sciences as well as an M.B.A. from The Pennsylvania State University. He was previously a board member of GlyPharma, a Montreal-based developer of innovative therapeutic medicines, and K2 Biotechnology Ventures, an organization dedicated to founding and operating life science companies emerging from universities.
Gordon Bean
Chief Financial Officer
​
Gordon Bean joined EVOME Medical Technologies as the VP of Finance in May 2024 and was recently promoted to Chief Financial Officer. He has over 20 years of senior financial leadership in manufacturing, life sciences, professional services and other areas. He began his professional career as an auditor.
​
Prior to EVOME, Gordon was the Corporate Controller at 3Step Sports, the largest provider of youth sports activities in the country. There he was responsible for all aspects of accounting, including treasury, collections, payables, audit and payroll. Before that he was the Corporate Controller at Keolis Transit America, a division of Keolis, which is a 6.5 billion Euro a year transportation company. In addition to managing the accounting and reporting function at Keolis Transit America, he played an integral role in the implementation of the new ERP system.
​
Gordon is a licensed CPA and has been one since 2000. Gordon has a Master’s degree in Accounting from Bentley College where he graduated with Distinction. He also holds Bachelor of Science degrees in Biology and Psychology from Concordia University. In his spare time, he writes fiction and has since published three books with a fourth on the way.
William Hauer
Vice President of Marketing and Sales
​
William was appointed Vice President of Marketing and Sales on October 1, 2023. William has over 35 years of life sciences experience in commercial leadership, new product launches and optimizing sales and sales operations. William has previously held marketing and sales leadership positions with PAI Pharmaceuticals, Quintiles, The Caswood Group and Schering Plough.
​
William has a long history of opening new and expanding existing sales channels for a broad spectrum of life sciences products including branded pharmaceuticals, medical devices, medical services, and outsourced sales and tele sales functions.
​
William has a BA degree from Bernard Baruch College, C.U.N.Y.
Carmine Tronolone
General Manager
​
Carmine Tronolone assumed the role of General Manager at Biodex in August 2023, bringing with him an impressive background in manufacturing and a passion for fostering a culture of innovation.
​
Carmine is a seasoned professional with over a decade of experience in manufacturing. His career has been defined by a remarkable aptitude for leadership, where he has consistently achieved outstanding results across various departments and projects.
​
In his current capacity as General Manager, Carmine oversees every facet of the production department. His primary focus is ensuring the efficient and effective manufacturing of products, aligned with Biodex’s strategic objectives and uncompromising quality standards.
​
Carmine is a graduate of Binghamton University. He has also earned a Master’s Certificate in Lean Manufacturing from the University of Michigan. When he is not working, Carmine enjoys spending time with his family. He also enjoys playing bocce ball and watching the Buffalo Bills on Sundays.
Shahidul Mahfuz
Engineering Manager
​
Shahidul Mahfuz is an experienced Engineer and a Designer, with over 22 years of experience in leading and developing high-performing engineering teams. Known for his exceptional technical acumen and strong leadership skills, Shahidul has a proven track record of delivering innovative solutions and driving projects to successful completion.
​
In his current role as Engineering Manager at Biodex, oversees a team of engineers and is responsible for driving the development of cutting-edge products. He has been with Biodex for 12+ years. With his dedication to innovation, strong leadership, and technical expertise, he is committed to achieving excellence in engineering and fostering a culture of continuous improvement within his teams. He is very passionate about User eXperience (UX) that makes Biodex product more useful at practical level. Lead the deign team for Biodex’s flagship product ensuring UX.
​
Throughout his career, Shahidul has worked in various industries, including software development, commercial bank, and manufacturing. He is highly skilled in project management, resource allocation, and fostering a collaborative work environment. His ability to align engineering goals with business objectives has consistently resulted in increased efficiency and product quality.
​
Shahidul holds a Bachelor’s degree in Computer Science & Engineering and a Master’s in Business Administration, which provides him with a unique blend of technical expertise and business acumen. He completed his certification of Google Project Management, and Google UX Design in 2021. Outside of work, he enjoys staying up-to-date with the latest industry trends and spending time with family.
Heydi Benson
Director of Human Resources
​
Heydi Benson assumed the role of Director of Human Resources at Evome in August of 2023.Heydi is a seasoned Human Resources professional with over a decade of experience in the field. As the Director of Human Resources at Biodex Medical systems, Heydi has been instrumental in shaping the company’s HR policies and fostering a positive workplace culture.
Heydi began her career in HR after earning her bachelor’s degree in business administration from Southern New Hampshire University. She quickly rose through the ranks, demonstrating a keen understanding of employee relations, talent acquisition, and organizational development. Her ability to navigate complex HR challenges and implement effective solutions has earned her a reputation as a trusted leader and advisor.
Throughout her career, Heydi has been committed to promoting diversity, equity, and inclusion within the workplace. She has spearheaded numerous initiatives aimed at creating a more inclusive environment, including the development of mentorship programs and diversity training workshops. In her free time, she enjoys hiking, reading, and spending time with her family.
EVOME MEDICAL TECHNOLOGIES
Board of Directors
.jpg)
.jpg)
.jpg)
Executive Director
Mike Seckler
Chief Executive Officer (CEO) of Salona Global
Mike Seckler was appointed Permanent Chief Executive Officer (CEO) of EVOME Medical Technologies in July 2023, following one month as interim CEO. He has more than 30 years of life sciences experience commercializing and developing innovative medicines, medical devices, and diagnostics for patients across a wide range of therapeutic areas.
Chairman and Executive Director
Ken Kashkin, MD
​COO of Chromocell Corporation
Former CMO, Ferring Pharma (Valued at over US$1B)
Former Sen. Executive at Abbot Laboratories (NYSE:ABT)
Former Vice President at Baxter (NYSE: BAX)
Former Professor, Yale University Medical School
​Dr. Ken Kashkin brings over 30 years of experience in medical devices, research and development, and corporate governance to the board. An expert physician, Dr. Kashkin serves as a technical medical expert on all transactions for the Company. Dr. Kashkin received his undergraduate and medical degrees from University of California, Los Angeles and completed his education at the Yale University School of Medicine.
Non-Executive Director
Lana Newishy
Lana Newishy is a senior executive with over 20 years of cross-functional leadership experience in transformation, operations, strategy and finance with Fortune 500 companies. Her expertise extends to collaborating with top-notch consulting and M&A firms, where she's worked on transformation and acquisition or divestment deals and has had her own practice in the field.
Lana is also an accomplished entrepreneur, having launched and operated two startups, and has a passion for the not-for-profit world where she served as a COO of a global organization.
Outside of her career, Lana enjoys mentoring entrepreneurs at different stages of their business lifecycle and participating in the Alumnae Network for Harvard Women as a steering committee member.
Member of the Board of Directors
Wayne Anderson
Wayne Anderson was appointed to the Board of Directors in February 2024. He is an executive with extensive marketing and general management experience leading small and large companies. He has extensive experience in the pharmaceutical and biopharmaceutical industry at two large companies. At Schering-Plough and Ferring Pharmaceuticals, he had wide range of experience in marketing and sales positions leading up to Vice-President of Marketing and later Vice-President of Marketing/Sales for Oncology Biotech.
He retired as President/CEO of Ferring Pharmaceuticals after working 13 years. He has built Ferring, a smaller biopharmaceutical company from $1MM to over $300MM in the U.S. Launched into a new category in 1997 as an unknown (infertility) and became #1 in Rx’s by 2005. Licensed and launched a second brand into the osteoarthritis space again as an unknown and became #2. Drove product development in the U.S. as Chairman of the U.S. Drug Development. Served on the Ferring Research Institute board for 2 years where he provided needed counsel on the candidacy of products in pre-clinical.
Member of the Board of Directors
William Garbarini
Bill Garbarini was appointed to the Board of Directors in February 2024. A C-level executive with a 30+ year diversified background within the life sciences/pharmaceutical/healthcare industry, Bill’s achievements cover multiple functional areas, from business development and M&A initiatives to operations to product introduction and life cycle management.
​
Recruited by the founders of Conceivable Life Sciences Inc. and TMRW Life Sciences Inc. to start new business to change the way IVF is practiced, Bill helped invent the world’s first automated, robotic storage platform for vitrified embryos and oocytes. In addition, he created the framework for the first automated, laboratory automation system, which will perform all IVF cell manipulations robotically.
​
He served as the COO of Reproductive Medicine Associates of New Jersey to build and grow a national IVF network. Bill’s signature accomplishment with the company was facilitating a merger with the Spanish company Instituto Valenciano de Infertilidad (IVI), thereby creating the world’s largest Assisted Reproduction group and achieving a near $1B valuation.
​
Previously, Bill enjoyed a distinguished 14-year career with Ferring Pharmaceuticals in which he played an instrumental role in the U.S. company’s industry reputation, market position, year-over-year growth, and overall success. As the inaugural head of the Orthopedics Business Unit, Bill introduced Euflexxa, which grew to sales of over $100 million.
​
Bill Garbarini earned his MBA from Fairleigh Dickinson University. An avid runner and soccer enthusiast, he is married with two children and lives in the Greater New York City area.
EVOME MEDICAL TECHNOLOGIES
​Advisors
EVOME Medical Technologies' board and management team brings decades of combined experience in medical device M&A and operational integration. Management's deep industry connections have created a deep and robust pipeline of potential acquisition targets.
​
The Company has retained Michael Dalsin (Former Chairman of PHM) and Roger Greene (Former Vice Chairman of PHM, Harvard Law School, JD) as industry advisors.
​
In addition to the board and advisor driven pipeline, the internal M&A team in the California corporate office systematically searches for potential acquisition targets globally. The internal acquisition team is structured around the key metrics and infrastructure that drove both DJO Global and PHM to success. Using a well-honed 12 point process, our internal M&A team has developed and continues to develop a deep pipeline of acquisition targets.